UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 645.

A

Abell, K; Bilancio, A; Clarkson, RWE; Tiffen, PG; Altaparmakov, AI; Burdon, TG; Asano, T; (2005) Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition. NATURE CELL BIOLOGY , 7 (4) pp. 392-398. 10.1038/ncb1242.

Abelman, W; Virchis, A; Yong, K; (2005) Extramedullary myeloma representing as a pericardial effusion with tamponade: Two case reports and a further review of 19 cases in the literature. LEUKEMIA & LYMPHOMA , 46 (1) pp. 137-142. 10.1080/10428190400011583.

Addison, EG; North, J; Bakhsh, I; Marden, C; Haq, S; Al-Sarraj, S; Malayeri, R; (2005) Ligation of CD8 alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. IMMUNOLOGY , 116 (3) 354 - 361. 10.1111/j.1365-2567.2005.02235.x. Gold open access

Adib, T.R.; (2005) Gene expression microarrays of serous ovarian adenocarcinoma. Doctoral thesis, University of London. Green open access
file

Aebischer, T; Bennett, CL; Pelizzola, M; Vizzardelli, C; Pavelka, N; Urbano, M; Capozzoli, M; (2005) A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (2) pp. 476-486. 10.1002/eji.200425674.

Agresti, A; Scaffidi, P; Riva, A; Caiolfa, VR; Bianchi, ME; (2005) GR and HMGB1 interact only within chromatin and influence each other's residence time. MOLECULAR CELL , 18 (1) pp. 109-121. 10.1016/j.molcel.2005.03.005.

Ah- See, ML; Burcombe, RJ; Daley, FM; Richman, P; Padhani, AR; Bentzen, SM; Fox, SB; (2005) Evaluation of tunour microvessel density and pericyte coverge index following neoadjuvant chemotherapy in primary breast cancer. In: (pp. 42s-42s).

Ah-See, M; Makris, A; Taylor, NJ; Stirling, JJ; Daley, FM; Richman, P; Harris, A; (2005) Correlating breast cancer and hypoxia status with MRI features. In: (pp. S205-).

Ah-See, M; Padhani, AR; Taylor, NJ; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; (2005) Lack of correlation between microvessel density & pericyte coverage index with breast cancer biposies & functional dynamic contrast-enhanced MRI-derived vascular parameters. In: (pp. S74-S75).

Ah-See, MW; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; Daley, FM; Padhani, AR; (2005) Evaluation of the effects of neoadjuvant chemotherapy on tumour microvessel density(MVD), pericyte coverage index(PCI), & vascular enodthelial growth factor(VEGF)in primary breast cancer. In: (pp. S224-).

Ahmed, F.; (2005) Homing and engraftment of CD34+ cells in the NOD/SCID model. Doctoral thesis, University of London. Green open access
file

Al-Adnani, M; Cannon, SR; Flanagan, AM; (2005) Chordomas do not express CD10 and renal cell carcinoma (RCC) antigen: an immunohistochemical study. Histopathology , 47 (5) pp. 535-537.

Al-Adnani, M; Idowu, B; Yu, L; Diss, TC; Lam, L; Gale, RE; O'Dell, E; (2005) Detection of a new mutation in fibrous dysplasia using a modified site directed mutagenesis methodology. In: JOURNAL OF PATHOLOGY. (pp. 7 - 7). JOHN WILEY & SONS LTD

Al-Adnani, M; Idowu, B; Yu, T; Diss, TC; Gale, RE; O'Dell, E; Flanagan, AM; (2005) A simple and reliable method for the molecular diagnosis of fibrous dysplasia. In: MODERN PATHOLOGY. (pp. 10A - 11A). NATURE PUBLISHING GROUP

Al-Dabbagh, R; Barrett, AW; Diss, T; Speight, PM; (2005) HPV is not associated with intra-oral squamous cell carcinoma. In: (pp. p. 1).

Al-Shahrour, F; Minguez, P; Vaquerizas, JM; Conde, L; Dopazo, J; (2005) BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res , 33 (Web Serv) W460-W464. 10.1093/nar/gki456.

Alonzi, R; Hoskin, P; (2005) Novel therapies in bladder cancer. CLINICAL ONCOLOGY , 17 (7) pp. 524-538.

Amis-, SJ; Coulter-Smith, SD; Crow, JC; Maclean, AB; Perrett, CW; (2005) Microvessel quantification in benign and malignant ovarian tumors. INT J GYNECOL CANCER , 15 (1) 58 - 65.

Andy, S; (2005) My dad’s fight with lung cancer. Daily Express pp. 30-31.

Arce, F; Gätjens-Boniche, O; Vargas, E; Valverde, B; Díaz, C; (2005) Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett , 229 (2) pp. 271-281. 10.1016/j.canlet.2005.06.047.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; Mackinnon, S; (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRITISH JOURNAL OF HAEMATOLOGY , 130 (3) pp. 363-372.

Ardeshna, KM; Kakouros, N; Qian, W; Powell, MG; Saini, N; D'Sa, S; Mackinnon, S; (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRIT J HAEMATOL , 130 (3) 363 - 372. 10.1111/j.1365-2141.2005.05603.x.

Arkenau, H; Kubicka, S; Greil, R; Schmoll, H; Seufferlein, T; Greaven, U; Grothey, A; (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis. EJC SUPPL , 3 (2) 168 - 168.

Arkenau, H; Porschen, R; (2005) Adjuvante Therapie des Kolonkarzinoms. In: Schoelmerich, J and Schmiegel, W, (eds.) Leitfaden Kolorektales Karzinom. (pp. 175-183). Uni-Med.-Verlag: Bremen, Germany.

Arkenau, H-T; Müssig, O; Buhr, T; Jend, HH; Porschen, R; (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol , 43 (8) pp. 719-722. 10.1055/s-2005-858259.

Arkenau, HT; Rettig, K; Porschen, R; (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis , 20 (3) pp. 258-261. 10.1007/s00384-004-0657-6.

Arno, G; Kaski, JC; Smith, DA; Akiyu, JP; Hughes, SE; Baboonian, C; (2005) Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Heart , 91 (4) pp. 521-525. 10.1136/hrt.2003.012054.

Attard, G; Plummer, RE; De Bono, JS; Bale, C; Fong, P; Barrett, M; Fox, NL; (2005) Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies. In: CLINICAL CANCER RESEARCH. (pp. 9060S - 9060S). AMER ASSOC CANCER RESEARCH

Aydinok, Y; Evans, P; Terzi, A; Cetiner, N; Porter, JB; (2005) Randomised prospective evaluation of iron balance, chelation efficiency, urine excretion and NTBI progression with deferiprone (DFP) or deferoxamine (DFO) monotherapy or with combined DFP plus DFO. In: BLOOD. (pp. 758A - 758A). AMER SOC HEMATOLOGY

Azzabi, A; Hughes, AN; Calvert, PM; Plummer, ER; Todd, R; Griffin, MJ; Lind, MJ; (2005) Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. BRIT J CANCER , 92 (6) 1006 - 1012. 10.1038/sj.bjc.6602438.

B

BBC, NB; (2005) Lung cancer scientist dies at 92. UNSPECIFIED

BBC, NO; (2005) 'Freeze therapy' for lung cancers. UNSPECIFIED

BBC, NO; (2005) Thalidomide slows cancer disease. UNSPECIFIED

BBC, NO; (2005) Warning to heed lung cancer signs. UNSPECIFIED

Barber, LJ; Ward, TA; Hartley, JA; McHugh, PJ; (2005) DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: Overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. MOL CELL BIOL , 25 (6) 2297 - 2309. 10.1128/MCB.25.6.2297-2309.2005. Gold open access

Bartesaghi, S; Marinovich, M; Corsini, E; Galli, CL; Viviani, B; (2005) Erythropoietin: A novel neuroprotective cytokine. NEUROTOXICOLOGY , 26 (5) 923 - 928. 10.1016/j.neuro.2005.01.016.

Bartlett, W; Skinner, JA; Gooding, CR; Carrington, RW; Flanagan, AM; Briggs, TW; Bentley, G; (2005) Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. Journal of Bone and Joint Surgery - Series B , 87 (5) pp. 640-645.

Bates, AW; (2005) Emblematic monsters: unnatural conceptions and deformed births in early modern Europe. (Vol.77).

Bates, AW; (2005) Good, common, regular, and orderly: Rarly modern classifications of monstrous births. SOC HIST MED , 18 (2) 141 - 158. 10.1093/sochis/hki029.

Bates, AW; Nale, K; (2005) Segmentation defects of the human axial skeleton without dysostoses or skeletal dysplasias. FETAL PEDIATR PATHOL , 24 (2) 121 - 127. 10.1080/15227950500257333.

Bax, BE; Richfield, L; Bain, MD; Mehta, AB; Chalmers, RA; Rampling, MW; (2005) Haemorheology in Gaucher disease. European Journal of Haematology , 75 (3) pp. 252-258.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2005) Lysosomal Diseases, Natural course, pathology and therapy. [Book]. (Vol.95, su). Taylor & Francis

Beck, S; (2005) Molecular variety club: (Epi)genetic resources for MHC/LRC-linked disease and evolution. In: TISSUE ANTIGENS. (pp. 357 - 358). BLACKWELL PUBLISHING

Beck, S; Berlin, K; Eckhardt, F; (2005) Das Epigenomprojekt. MEDIZINISCHE GENETIK , 17 (3) pp. 46-50.

Begent, RHJ; Kerr, P; Parkinson, H; Reddington, F; Wilkinson, JM; (2005) NCRI Informatics initiative. UNSPECIFIED

Bell, CG; Meyre, D; Samson, C; Boyle, C; Lecoeur, C; Tauber, M; Jouret, B; (2005) Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity. Diabetes , 54 (10) pp. 3049-3055.

Bell, CG; Walley, AJ; Froguel, P; (2005) The genetics of human obesity. Nat Rev Genet , 6 (3) pp. 221-234. 10.1038/nrg1556.

Bengala, C; Guarneri, V; Ledermann, J; Rosti, G; Wandt, H; Lotz, JP; Cure, JH; (2005) High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION , 36 (1) pp. 25-31. 10.1038/sj.bmt.1705007.

Benjamin, R; Streck, C; Ng, CYC; Singh, N; Khwaja, A; Pizzey, A; McIntosh, J; (2005) Effect of substained expression of human interferon-β by rAAV vector medicated gene transfer in xenograft models of acute leukaemia. In:

Bennett, CL; van Rijn, E; Jung, S; Inaba, K; Steinman, RM; Kapsenberg, ML; Clausen, BE; (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. JOURNAL OF CELL BIOLOGY , 169 (4) pp. 569-576. 10.1083/jcb.200501071. Green open access
file

Bentzen, SM; Atasoy, BM; Daley, FM; Dische, S; Richman, PI; Saunders, MI; Trott, KR; (2005) Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomised controlled trial. Journal of Clinical Oncology , 23 (24) pp. 5560-5567. 10.1200/jco.2005.06.411.

Beresford, M; Ah-See M L, T; N J, S; J J, M; A, DJA; Leach, MO; Padhani, AR; (2005) Inter-and intra-observer variability of DCE-MRI in breast cancer. In:

Beresford, M; Glynne-Jones, R; Richman, P; Makris, A; Mawdsley, S; Stott, D; Harrison, M; (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. CLINICAL ONCOLOGY , 17 (6) pp. 448-455.

Beresford, M; Padhani, AR; Goh, V; Makris, A; (2005) Imaging breast cancer response during neoadjuvant systemic therapy. Expert Review of Anticancer Therapy , 5 (5) pp. 893-905.

Beresford, MJ; Ah-See, M; Daley, F; Richman, P; Harris, A; Makris, A; (2005) The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary bresat cancer. In: (pp. S59-S59).

Beresford, MJ; Ah-See, ML; Burcombe, R; Dixon, J; Ostler, P; Harrsion, M; Pittam, R; (2005) Do pre-treatment haemaglobin levels predicct for response to neoadjuvant chemotherapy in breast cancer? In: (pp. 80s-80).

Beresford, MJ; Makris, A; Taylor, NJ; Stirling, JJ; Ah-See, M; d'Arcy, JA; Collins, D; (2005) Observer variability in dynamic contrast-enhanced MRI when used for prediction of response to neoadjuvant chemotherapy in primary breast cancer. In: (pp. S206-).

Betticher, D; von Rohr, A; Kovacsovics, T; Martinelli, G; Cerny, T; Linch, DC; Dyer, MJS; (2005) Sequential high-dose chemotherapy (SHDC) with autologous stem cell transplantation (ASCT) vs standard CHOP regimen for pts with untreated aggressive NHL. Result of the mistral trial from the Swiss Group for Clinical Cancer Research (SAKK). In: ANNALS OF ONCOLOGY. (pp. 100 - 101). OXFORD UNIV PRESS

Bilanges, B; Stokoe, D; (2005) Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi. Biochem J , 388 (Pt 2) pp. 573-583. 10.1042/BJ20041956.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; Baus Section Oncology Canc Registr, ; (2005) Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of < 10 ng/mL. BJU INT , 96 (3) 303 - 307. 10.1111/j.1464-410X.2005.05619.x.

Bloor, AJC; Thomson, K; Cooper, N; Peggs, KS; Mackinnon, S; (2005) Dose-escalated donor lymphocyte infusions post allogeneic transplantation in non-Hodgkin's lymphoma. In: BLOOD. (pp. 569A - 570A). AMER SOC HEMATOLOGY

Bochtler, W; Beth, M; Marsh, SGE; Muller, CR; (2005) Hlacore - A comprehensive low level HLA library for programmers. In: (Proceedings) 31st Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S49-S49). ELSEVIER SCIENCE INC

Boddy, AV; Plummer, ER; Todd, R; Sludden, J; Griffin, M; Robson, L; Cassidy, J; (2005) A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. CLIN CANCER RES , 11 (21) 7834 - 7840. 10.1158/1078-0432.CCR-05-0803.

Bose, F; Fugazza, C; Capelli, A; Ronzoni, L; Cappellini, MD; Jane, S; Cunningham, J; (2005) Functional interaction of CP2 with GATA-1 in the regulation of the expression of erythroid promoters. In: (Proceedings) 14th Conference on Hemoglobin Switching. (pp. pp. 119-120). ACADEMIC PRESS INC ELSEVIER SCIENCE

Bowen, DT; Frew, ME; Hills, R; Gale, RE; Wheatley, K; Groves, MJ; Langabeer, SE; (2005) RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. BLOOD , 106 (6) 2113 - 2119. 10.1182/blood-2005-03-0867.

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; Young, AM; (2005) A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. ANN INTERN MED , 143 (4) 265 - 273.

Bower, M; Nelson, M; Young, AM; Thirlwell, C; Newsom-Davis, T; Mandalia, S; Dhillon, T; (2005) Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J CLIN ONCOL , 23 (22) 5224 - 5228. 10.1200/JCO.2005.14.597.

Bower, M; Powles, T; Stebbing, J; Thirlwell, C; (2005) Potential antiretroviral drug interactions with cyclophosphamide, doxorubicin, and etoposide. J CLIN ONCOL , 23 (6) 1328 - 1329. 10.1200/JCO.2005.05.128.

Boxer, GM; Tsiompanou, E; Levine, T; Watson, R; Begent, RHJ; (2005) Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. TUMOR BIOL , 26 (1) 1 - 8. 10.1159/000084180.

Boyer, LA; Lee, TI; Cole, MF; Johnstone, SE; Levine, SS; Zucker, JP; Guenther, MG; (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell , 122 (6) pp. 947-956. 10.1016/j.cell.2005.08.020.

Braithwaite, D; Sutton, S; Mackay, J; Stein, J; Emery, J; (2005) Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detection and Prevention , 29 (5) pp. 433-439.

Brandts, CH; Bilanges, B; Hare, G; McCormick, F; Stokoe, D; (2005) Phosphorylation-independent stabilization of p27kip1 by the phosphoinositide 3-kinase pathway in glioblastoma cells. J Biol Chem , 280 (3) pp. 2012-2019. 10.1074/jbc.M408348200.

Braybrooke, JP; Slade, A; Deplanque, G; Harrop, R; Madhusudan, S; Forster, MD; Gibson, R; (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res , 11 (4) pp. 1512-1520. 10.1158/1078-0432.CCR-04-0155.

Brenner, C; Deplus, R; Didelot, C; Loriot, A; Vire, E; De Smet, C; Gutierrez, A; (2005) Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J , 24 (2) 336 - 346. 10.1038/sj.emboj.7600509.

Brittan, M.; (2005) Bone marrow cells contribute to tissue regeneration in the intestine and skin. Doctoral thesis, University of London. Green open access
file

Brooks, S; Bownes, P; Lowe, G; Bryant, L; Hoskin, PJ; (2005) Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 934-939.

Brown, P; Marafioti, T; Kusec, R; Banham, AH; (2005) The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. J Mol Histol , 36 (4) pp. 249-256. 10.1007/s10735-005-6521-3.

Buchmueller, KL; Taherbhai, Z; Howard, CM; Bailey, SL; Nguyen, B; O'Hare, C; Hochhauser, D; (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burcombe, RJ; Makris, A; Richman, PI; Daley, FM; Noble, S; Pittam, M; Wright, D; (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer , 92 (1) pp. 147-155.

Burk, K; (2005) George Saintsbury: the Man and His Glass. The World of Fine Wine , None (7) pp. 50-55.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; Hancock, B; (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 130 (4) pp. 536-541.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; Hancock, B; (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. Br J Haematol , 130 (4) pp. 536-541. 10.1111/j.1365-2141.2005.05640.x.

Butcher, LM; Meaburn, E; Dale, PS; Sham, P; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol.Psychiatry , 10 (4) pp. 384-392. 10.1038/sj.mp.4001589.

Butcher, LM; Meaburn, E; Knight, J; Sham, PC; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) SNPs, microarrays and pooled DNA: identification of four loci associated with mild mental impairment in a sample of 6000 children. Hum.Mol.Genet. , 14 (10) pp. 1315-1325. 10.1093/hmg/ddi142.

C

CHICKEN, DW; FALZON, M; KOCJAN, G; DOUEK, M; SAINSBURY, JRS; KESHTGAR, MRS; (2005) Intraoperative Touch Imprint Cytology of Clinically Apparently Involved Sentinel Node Metastases: Why Bother?. In: (pp. p. 31).

Cahetterjee, R; Palla, K; McGarrigle, HH; Mackinnon, S; Kottaridis, PD; (2005) Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies. Bone Marrow Transplantation , 35 321-.

Cairo, S; De Falco, F; Pizzo, M; Salomoni, P; Pandolfi, PP; Meroni, G; (2005) PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. ONCOGENE , 24 (13) 2195 - 2203. 10.1038/sj.onc.1208338.

Calvert, AH; (2005) Fishing for new drugs. J CLIN ONCOL , 23 (31) 7780 - 7782. 10.1200/JCO.2005.08.004.

Calvert, H; Twelves, C; Ranson, M; Anthoney, A; Plummer, R; Fettner, S; Dayaram, B; (2005) The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 210S - 210S). AMER SOC CLINICAL ONCOLOGY

Camilleri, RS; Cohen, H; (2005) No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism. BLOOD COAGUL FIBRIN , 16 (3) 193 - 198.

Camilleri, RS; Mackie, IJ; Scully, M; Machin, SJ; Cohen, H; (2005) A genetic basis for adult onset TTP? In: BLOOD. (pp. 357A - 357A). AMER SOC HEMATOLOGY

Capponcelli, S; Pedrini, E; Cerone, MA; Corti, V; Fontanesi, S; Alessio, M; Bachi, A; (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) pp. 94-103. 10.1002/humu.20192.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The Quality of Fresh-Frozen Plasma (FFP) Produced from Whole Blood Stored at 4°C Overnight. Transfusion , 45 pp. 1342-1348.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. TRANSFUSION , 45 (8) 1342 - 1348. 10.1111/j.1537-2995.2005.00219.x.

Carroll, VA; Nikitenko, LL; Bicknell, R; Harris, AL; (2005) Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2. ARTERIOSCL THROM VAS , 25 (4) 736 - 741. 10.1161/01.ATV.0000157980.15710.2b.

Casely-Hayford, MA; Pors, K; James, CH; Patterson, LH; Hartley, JA; Searcey, M; (2005) Design and synthesis of a DNA-crosslinking azinomycin analogue. ORG BIOMOL CHEM , 3 (19) 3585 - 3589. 10.1039/b508908e.

Cerone, MA; Autexier, C; Londoño-Vallejo, JA; Bacchetti, S; (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) pp. 7893-7901. 10.1038/sj.onc.1208934.

Cerone, MA; Ward, RJ; Londoño-Vallejo, JA; Autexier, C; (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) pp. 585-589.

Chang, JC; Hisenback, SG; Yee, D; Tsimelzon, A; Harrison, M; Gutierrez, CM; Elledge, RM; (2005) Gene expression profiles as predictors of response to neoadjuvant taxotere and adriamycin/cyroxan:a propsective randomized trial in breast cancers. In: (pp. S31-S31).

Charrier, S; Dupre, L; Blundell, M; Scaramuzza, S; Jeanson, L; Vainchenker, W; Danos, O; (2005) Functional correction of lymphocytes and dendritic cells of patients with WAS or XLT, using lentiviral vectors targeting the expression of WAS protein to hematopoietic cells. Blood , 106 (11) 852A-852A.

Charrier, S; Stockholm, D; Seye, K; Opolon, P; Taveau, M; Gross, D-A; Bucher-Laurent, S; (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther , 12 (7) pp. 597-606. 10.1038/sj.gt.3302440.

Chatterjee, R; Palla, K; McGarrigle, HH; Mckinnon, S; Kottaridis, PD; (2005) Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies. BONE MARROW TRANSPL , 35 (2) 209 - 210. 10.1038/sj.bmt.1704744.

Chatterjee, R; Shah, F; Davis, B; Byers, DM; Sooranna, S; Bajoria, R; Pringle, J; (2005) Prospective study of histomormometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteoporosis. In: JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. (pp. 375A - 376A). ELSEVIER SCIENCE INC

Chen-Scarabelli, C; Hughes, SE; Landon, G; Rowley, P; Allebban, Z; Lawson, N; Saravolatz, L; (2005) A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. EUR J HEART FAIL , 7 (5) 927 - 930. 10.1016/j.ejheart.2004.09.012.

Chester, KA; Baker, M; Mayer, A; (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol , 1 (4) pp. 549-559. 10.1586/1744666X.1.4.549.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshina, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin's lymphoma: A questionnaire-based survey evaluating current practice in the United Kingdom. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 26 - 27). BLACKWELL PUBLISHING

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. BRIT J HAEMATOL , 131 (2) 193 - 200. 10.1111/j.1365-2141.2005.05756.x.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshna, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK (vol 131, pg 193, 2005). BRIT J HAEMATOL , 131 (5) 673 - 673.

Chicken, DW; Clarke, BR; Johnson, KS; Lee, AC; Briggs, G; Pickard, CDO; Falzon, M; (2005) Optical biopsy: breast cancer diagnoses at the speed of light. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S43 - S43). SPRINGER

Chicken, DW; Lee, AC; Johnson, KS; Clarke, B; Falzon, M; Bigio, IJ; Bown, SG; (2005) Elastic scattering spectroscopy for detection of sentinel lymph node metastases in breast carcinoma. Optics InfoBase Conference Papers

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, CK; Patch, D; Dhillon, AP; (2005) Transjugular liver biopsy: Is it effective for accurate histological interpretation? In: GUT. (pp. A26 - A26). B M J PUBLISHING GROUP

Clark, BR; Johnson, K; Mackenzie, GD; Novelli, MR; Selvasekar, CR; Thorpe, SM; Bown, SG; (2005) In-vivo detection of pre-cancerous changes in Barrett's esophagus using elastic scattering spectroscopy (ESS). In: (Proceedings) SPIE - the International Society for Optical Engineering. (pp. 5862OB-). International Society for Optical Engineering: USA.

Clarke, DL; Belvisi, MG; Smith, SJ; Hardaker, E; Yacoub, MH; Meja, KK; Newton, R; (2005) Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol , 288 (2) L238-L250. 10.1152/ajplung.00313.2004.

Cleator, SJ; Makris, A; Ashley, SE; Lal, R; Powles, TJ; (2005) Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology , 16 (2) pp. 267-272.

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks inmammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Clingen, PH; De Silva, IU; McHugh, PJ; Ghadessy, FJ; Tilby, MJ; Thurston, DE; Hartley, JA; (2005) The XPF-ERCC1 endonuclease and homologous recon bination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. NUCLEIC ACIDS RES , 33 (10) 3283 - 3291. 10.1093/nar/gki639. Gold open access

Coakley, M; Self, R; Marchant, W; Mackie, I; Mallett, SV; Mythen, M; (2005) Use of the platelet function analyser (PFA-100 (R)) to quantify the effect of low dose aspirin in patients with ischaemic heart disease. ANAESTHESIA , 60 (12) 1173 - 1178. 10.1111/j.1365-2044.2005.04291.x.

Cobbold, M; Khan, N; Pourgheysari, B; Tauro, S; McDonald, D; Osman, H; Assenmacher, M; (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J EXP MED , 202 (3) 379 - 386. 10.1084/jem.20040613.

Coelho, JJ; Arnold, A; Nayler, J; Tischkowitz, M; Mackay, J; (2005) An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. European Journal of Cancer , 41 (15) pp. 2257-2261.

Cohen, H; (2005) Analysis of the Sliding Window Powering Algorithm. J. Cryptology , 18 (1) pp. 63-76. 10.1007/s00145-004-0218-8.

Cohen, H; (2005) Inherited thrombophilia and pregnancy loss-epidemiology. THROMBOSIS RESEARCH , 115 13 - 17.

Cohen, H; Scully, M; Starke, R; Mackie, I; Machin, S; (2005) Successful pregnancy outcome of three patients with chronic, unremitting Thrombotic Thrombocytopenic Purpura. In: THROMBOSIS RESEARCH. (pp. 116 - 116). PERGAMON-ELSEVIER SCIENCE LTD

Collin, MP; Hart, DN; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Dickinson, AM; (2005) The fate of human Langerhans cells in hematopoietic stem cell transplantation. In: BLOOD. (pp. 170A - 170A). AMER SOC HEMATOLOGY

Conde, L; Vaquerizas, JM; Ferrer-Costa, C; de la Cruz, X; Orozco, M; Dopazo, J; (2005) PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes. Nucleic Acids Res , 33 (Web Serv) W501-W505. 10.1093/nar/gki476.

Condliffe, AM; Davidson, K; Anderson, KE; Ellson, CD; Crabbe, T; Okkenhaug, K; Vanhaesebroeck, B; (2005) Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. BLOOD , 106 (4) pp. 1432-1440. 10.1182/blood-2005-03-0944.

Conti, L; Pollard, SM; Gorba, T; Reitano, E; Toselli, M; Biella, G; Sun, Y; (2005) Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biology , 3 (9) , Article e283. 10.1371/journal.pbio.0030283. Green open access
file

Cooper, N; Avivi, I; Karl, PS; Hart, DQ; Thomson, K; Bloor, AJC; Goldstone, AH; (2005) The use of PET scans to direct immunotherapy following reduced intensity stem cell transplants in adults with lymphoid malignancies. In: BLOOD. (pp. 438B - 438B). AMER SOC HEMATOLOGY

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. BRIT J CANCER , 92 (11) 1997 - 2003. 10.1038/sj.bjc.6602586.

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. British Journal of Cancer , 92 (11) pp. 1997-2003.

Crawley, C; Lalancette, M; Szydlo, R; Gilleece, M; Peggs, K; Mackinnon, S; Juliusson, G; (2005) Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT. BLOOD , 105 (11) 4532 - 4539. 10.1182/blood-2004-06-2387.

Cross, JGR; Harrison, GA; Coggill, P; Sims, S; Beck, S; Deakin, JE; Graves, JAM; (2005) Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. CYTOGENET GENOME RES , 111 (2) 110 - 117. 10.1159/000086379.

Cuomo, ME; Knebel, A; Platt, G; Morrice, N; Cohen, P; Mittnacht, S; (2005) Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin.CDK6 phosphorylation of caldesmon. J Biol Chem , 280 (43) pp. 35844-35858. 10.1074/jbc.M503877200. Gold open access

Cutillas, PR; Geering, B; Waterfield, MD; Vanhaesebroeck, B; (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics , 4 (8) pp. 1038-1051. 10.1074/mcp.M500078-MCP200.

D

Damien, E; Causa, F; Ambrosio, L; Revell, PA; (2005) In vivo characterisation of a novel hydrophilic composite for total intervertebral disc substitution. BIOCERAMICS 17 , 284-28 pp. 795-798.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. BIOORG MED CHEM LETT , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) pp. 177-180. 10.1016/j.bmcl.2004.10.021.

Dark, GG; Calvert, AH; Grimshaw, R; Poole, C; Swenerton, K; Kaye, S; Coleman, R; (2005) Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group. JOURNAL OF CLINICAL ONCOLOGY , 23 (9) 1859 - 1866. 10.1200/JCO.2005.02.028.

Davidoff, AM; Gray, JT; Ng, CYC; Zhang, YB; Zhou, JF; Spence, Y; Bakar, Y; (2005) Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. MOL THER , 11 (6) 875 - 888. 10.1016/j.ymthe.2004.12.022.

Davidoff, AM; Ng, CYC; Zhang, YB; Streck, CJ; Mabry, SJ; Barton, SH; Baudino, T; (2005) Careful decoy receptor titering is required to inhibit tumor angiogenesis while avoiding adversely altering VEGF bioavailability. MOL THER , 11 (2) 300 - 310. 10.1016/j.ymthe.2004.09.014.

Davies, DL; Kochegarov, AA; Kuo, S; Kulkarni, AA; Woodward, JJ; King, BF; Arkana, RL; (2005) Ethanol differentially affects ATP-gated P2X<sub>3</sub> and P2X<sub>4</sub> receptor subtypes expressed in <i>Xenopus</i> oocytes. Neuropharmacology , 49 (2) pp. 243-253.

Davies, H; Hunter, C; Smith, R; Stephens, P; Greenman, C; Bignell, G; Teague, B; (2005) Somatic mutations of the protein kinase gene family in human lung cancer. CANCER RES , 65 (17) 7591 - 7595. 10.1158/0008-5472.CAN-05-1855.

Deakin, JE; Papenfuss, AT; Cross, JGR; Belov, K; Coghill, P; Palmer, S; Sims, S; (2005) Comparative analysis and evolution of the MHC class III region. In: TISSUE ANTIGENS. (pp. 395 - 395). BLACKWELL PUBLISHING

Dearling, JLJ; Flynn, AA; Beken, L; Petrie, IA; El-Emir, E; Boxer, GM; Green, AJ; (2005) Dose Estimation in a 3D Tumour Reconstruction -Impact of the Heterogeneity of TumourPathophysiology on RIT and EBRT. In: (pp. S83-S83). SPRINGER

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2005) Radioimmunotherapy Combined with Anti-Hypoxia Therapy 2DG Results in Reduction of Therapeutic Efficacy. In: (pp. S48-S48). SPRINGER

Dearling, JLJ; Qureshi, U; Begent, RHJAPRB; (2005) RIT given in combination with anti-hypoxia therapy 2DG leads to loss of therapeutic efficacy. In: (Proceedings) NCRI cancer Conference Proceedings. (pp. 66-).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, G; Begent, RHJAPRB; (2005) Quantitative autoradiography revelas higher antibody uptake in peripheral intrahepatic deposits than in central deposits. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 56-).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, GM; Begent, RHJ; Pedley, RB; (2005) Analysis of Antibody Distribution Reveals Higher Uptake in Peripheral Intrahepatic Deposits Than Central Deposits. In: (pp. S83-S83). SPRINGER

Deborah, H; (2005) I haven’t smoked for 23 years yet now I face the serves-you-right stigma of this forgotten disease. Evening Standard pp. 27-28.

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; Devereux, S; (2005) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukemia: A BSBMT study. In: BLOOD. (pp. 813A - 813A). AMER SOC HEMATOLOGY

Dhami, P; Coffey, AJ; Abbs, S; Vermeesch, JR; Dumanski, JP; Woodward, KJ; Andrews, RM; (2005) Exon array CGH: Detection of copy-number changes at the resolution of individual exons in the human genome. AM J HUM GENET , 76 (5) 750 - 762.

Dickson, PV; Nathwani, AC; Davidoff, AM; (2005) Delivery of antiangiogenic agents for cancer gene therapy. TECHNOL CANCER RES T , 4 (4) 331 - 341.

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 13A-13A). NATURE PUBLISHING GROUP

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 13A-13A). NATURE PUBLISHING GROUP

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time RT-PCR. In: (Proceedings) 3rd Joint Meeting of the British Division of the International-Academy-of-Pahtology/Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. p. 54). JOHN WILEY & SONS LTD

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) A real-time RT-PCR method for detection of EWS/ATF1 fusion transcripts in clear cell sarcoma using paraffin-embedded material. In: (Proceedings) 3rd Joint Meeting of the British Division of the International-Academy-of-Pahtology/Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. p. 53). JOHN WILEY & SONS LTD

Dogan, A; Du, MQ; Isaacson, PG; (2005) A relapsing inflammatory syndrome and HHV-8. NEW ENGLAND JOURNAL OF MEDICINE , 353 (16) p. 1746. Green open access
file

Dotti, G; Savoldo, B; Pule, M; Straathof, KC; Biagi, E; Yvon, E; Vigouroux, S; (2005) lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. BLOOD , 105 (12) 4677 - 4684. 10.1182/blood-2004-08-3337. Green open access
file

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, A; Patch, D; Dhillon, AP; (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. BIOL BLOOD MARROW TR , 11 (10) 805 - 813. 10.1016/j.bbmt.2005.06.008.

Duarte, RF; Delgado, J; Shaw, BE; Wrench, DJ; Ethell, M; Patch, D; Dhillon, AP; (2005) Histological features in the liver biopsy predict the clinical outcome of patients with graft-versus-host disease of the liver. In: BONE MARROW TRANSPLANTATION. (pp. S43 - S43). NATURE PUBLISHING GROUP

Duarte, RF; Delgado, J; Shaw, BE; Wrench D J, E; M, P; D, D; A P, M; (2005) Histologic features of the liver biopsy predict the clinical outcome for patients with graft-verus-host disease of the liver. Biology of Blood and Marrow Transplantation , 11 pp. 805-813.

Dudderidge, TJ; Haynes, SVZ; Davies, AJW; Jarmulowicz, M; Al-Akraa, MA; (2005) Vesicocervical fistula: rare complication of cesarean section demonstrated by magnetic resonance imaging. Urology , 65 (1) 174-. 10.1016/j.urology.2004.07.001.

Dudderidge, TJ; Stoeber, K; Loddo, M; Atkinson, G; Fanshawe, T; Griffiths, DF; Williams, GH; (2005) Mcm2, Geminin, and Ki67 define proliferative state and are prognostic markers in renal cell carcinoma. CLIN CANCER RES , 11 (7) 2510 - 2517.

Dudderidge, TJ; Stoeber, K; Loddo, M; Atkinson, G; Fanshawe, T; Griffiths, DF; Williams, GH; (2005) Mcm2, geminin and Ki67 define proliferative state and are predictors of outcome in renal cell carcinoma. Clinical Cancer Research , 11 pp. 2510-2517.

de Bruin, EC; van de Pas, S; Lips, EH; van Eijk, R; van der Zee, MM; Lombaerts, M; van Wezel, T; (2005) Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics , 6 , Article 142. 10.1186/1471-2164-6-142. Green open access
file

de Groot, NG; Garcia, CA; Verschoor, EJ; Doxiadis, GGM; Marsh, SGE; Otting, N; Bontrop, RE; (2005) Reduced MIC gene repertoire variation in west African chimpanzees as compared to humans. MOLECULAR BIOLOGY AND EVOLUTION , 22 (6) pp. 1375-1385. 10.1093/molbev/msi127.

E

Edwards, C.S.; (2005) The roles of vaccinia virus proteins in kinesin-dependent microtubule transport. Doctoral thesis, University of London. Green open access
file

Eguchi, M; Eguchi-Ishimae, M; Green, A; Enver, T; Greaves, M; (2005) Directing oncogenic fusion genes into stem cells via an SCL enhancer. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 102 (4) pp. 1133-1138. 10.1073/pnas.0405318102.

El, EE; Dearling, J; Huhalov, A; Neri, D; Begent, RHJ; Pedley, RB; (2005) Targeting tumour vasculature in human colorectal xenografts using against the extra-domain B of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings.

El-Emir, E; Boxer, GM; Petrie, IA; Boden, RW; Dearling, JLJ; Begent, RHJ; Pedley, RB; (2005) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. EUR J CANCER , 41 (5) 799 - 806. 10.1016/j.ejca.2005.01.001.

Enver, T; Huang, S; (2005) Mathematical modeling of transcriptional regulatory circuits defines cell fate attractors and predicts the genome-scale behaviour of haemopoietic progenitor cells undergoing a binary cell fate decision. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 135B-135B). AMER SOC HEMATOLOGY

Enver, T; Soneji, S; Joshi, C; Brown, J; Iborra, F; Orntoft, T; Thykjaer, T; (2005) Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. HUMAN MOLECULAR GENETICS , 14 (21) pp. 3129-3140. 10.1093/hmg/ddi345.

Enver, T; Tsuzuki, S; Brown, J; Hong, DL; Gupta, R; Ford, T; Egucchi, MI; (2005) Developmental impact of leukemic fusion genes on stem cell fate. HEMATOPOIETIC STEM CELLS V , 1044 pp. 16-23. 10.1196/annals.1349.003.

Ezoe, S; Matsumura, I; Gale, K; Satoh, Y; Ishikawa, J; Mizuki, M; Takahashi, S; (2005) GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. JOURNAL OF BIOLOGICAL CHEMISTRY , 280 (13) pp. 13163-13170. 10.1074/jbc.M413461200. Gold open access

F

Ffolkes, LV; Agrawal, V; Parkinson, MC; Benjamin, E; (2005) The effects of androgen therapy on the female genital tract. In: MODERN PATHOLOGY. (pp. 183A - 183A). NATURE PUBLISHING GROUP

Ffolkes, LV; Agrawal, V; Parkinson, MC; Benjamin, E; (2005) The effects of androgen therapy on the female genital tract. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 183A-183A). NATURE PUBLISHING GROUP

Field, D; Feil, EJ; Wilson, GA; (2005) Databases and software for the comparison of prokaryotic genomes. Microbiology , 151 (Pt 7) pp. 2125-2132.

Fielding, AK; (2005) Measles as a potential oncolytic virus. REV MED VIROL , 15 (2) 135 - 142. 10.1002/rmv.455.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; Brit Soc Haematology Taskforce Hae, ; (2005) An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. BRIT J HAEMATOL , 131 (2) 156 - 165. 10.1111/j.1365-2141.2005.05739.x.

Fleenor, D; Oden, J; Kelly, PA; Mohan, S; Alliouachene, S; Pende, M; Wentz, S; (2005) Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology , 146 (1) pp. 103-112. 10.1210/en.2004-0744.

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Gerrard, G; Patel, B; Richards, S; (2005) Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Patel, B; Richards, S; Fielding, A; (2005) Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 424A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Richards, S; Fielding, A; Goldstone, AH; (2005) The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; Khaliq, S; Pasha, S; Willis, C; Abbasi, R; Tee, L; (2005) Locus heterogeneity in autosomal recessive congenital cataracts: linkage to 9q and germline HSF4 mutations. HUM GENET , 117 (5) 452 - 459. 10.1007/s00439-005-1309-9.

Forshew, T; Khaliq, S; Tee, L; Smith, U; Johnson, CA; Mehdi, SQ; Maher, ER; (2005) Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism. Clin Genet , 68 (2) pp. 182-184. 10.1111/j.1399-0004.2005.00460.x.

Freeman, L; Hewison, M; Hughes, SV; Evans, KN; Hardie, D; Means, TK; Chakraverty, R; (2005) Expression of 11 beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. BLOOD , 106 (6) 2042 - 2049. 10.1182/blood-2005-01-0186.

G

Gale, RE; Hills, R; Kottaridis, P; Srirangan, S; Wheatley, K; Burnett, A; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials. Blood , 106 (10) pp. 3658-3665. 10.1182/blood-2005-03-1323.

Gale, RE; Hills, R; Kottaridis, PD; Srirangan, S; Wheatley, K; Burnett, AK; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials. BLOOD , 106 (10) 3658 - 3665. 10.1182/blood-2005-03-1323. Green open access
file

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. BLOOD , 106 (12) 3768 - 3776. Green open access
file

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood , 106 (12) pp. 3768-3776. 10.1182/blood-2005-04-1746.

Galluzzi, L; Pinti, M; Guaraldi, G; Mussini, C; Troiano, L; Roat, E; Giovenzana, C; (2005) Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy. Antivir Ther , 10 Sup M91-M99.

Galluzzi, L; Pinti, M; Troiano, L; Prada, N; Nasi, M; Ferraresi, R; Salomoni, P; (2005) Changes in mitochondrial RNA production in cells treated with nucleoside analogues. ANTIVIR THER , 10 (1) 191 - 195.

Ganeshaguru, K; Folarin, NI; Baker, RJ; Casanova, AM; Bhimjiyani, A; Hoffbrand, AV; Mehta, AB; (2005) An in vitro model of proliferating CLL cells for drug sensitivity analysis. In: BLOOD. (pp. 829A - 829A). AMER SOC HEMATOLOGY

Gardiner, C; Pennaneac'h, C; Walford, C; Machin, SJ; Mackie, IJ; (2005) An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. BRIT J HAEMATOL , 128 (6) 842 - 848. 10.1111/j.1365-2141.2005.05394.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. BRIT J HAEMATOL , 128 (2) 242 - 247. 10.1111/j.1365.2141.2004.05300.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol , 128 (2) pp. 242-247. 10.1111/j.1365-2141.2004.05300.x.

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). BLACKWELL PUBLISHING

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised controlled trial of patient self management of oral anticoagulation compared with patient self-testing. In: (Proceedings) British society for haematology annual scientific meeting.

Garrett, MD; Mittnacht, S; (2005) Editorial overview: The genetics and biology of cancer - revealing avenues for therapy. CURRENT OPINION IN GENETICS & DEVELOPMENT , 15 (1) pp. 1-4. 10.1016/j.gde.2004.12.012.

Garrett, MD; Mittnacht, S; (2005) Oncogenes and cell proliferation: The genetics and biology of cancer - Revealing avenues for therapy. Current Opinion in Genetics and Development , 15 (1) pp. 1-4. 10.1016/j.gde.2004.12.012.

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, A; (2005) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. European Journal of Pharmacology , 609 (1-3) pp. 34-39.

Gibbs, DD; Theti, DS; Wood, N; Green, M; Raynaud, F; Valenti, M; Forster, MD; (2005) BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer Res , 65 (24) pp. 11721-11728. 10.1158/0008-5472.CAN-05-2034.

Glasow, A; Barrett, A; Gupta, R; Grimwade, D; von Lindern, M; Enver, T; Zelent, A; (2005) Expression of ATRA inducible RAR alpha 2 isoform is deregulated in AML. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 351A-351A). AMER SOC HEMATOLOGY

Glassford, J; Brosens, JJ; Turner, M; Lam, EWEA; (2005) Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. European Journal of Immunology , 95 (9) pp. 2748-2761.

Godfrey, A; Anderson, J; Papanastasiou, A; Takeuchi, Y; Boshoff, C; (2005) Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA. BLOOD , 105 (6) 2510 - 2518. 10.1182/blood-2004-08-3052.

Gomez, K; McVey, JH; Tuddenham, E; (2005) Inhibition of coagulation by macromolecular complexes. Haematologica , 90 (11) pp. 1570-1576. Gold open access

Gomez-Escobar, N; Bennett, C; Prieto-Lafuente, L; Aebischer, T; Blackburn, CC; Maizels, RM; (2005) Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biology , 3 , Article 108. 10.1186/1741-7007-3-8. Green open access
file

Gondek, DC; Lu, LF; Quezada, SA; Sakaguchi, S; Noelle, RJ; (2005) Cutting edge: Contact-mediated suppression by CD4(+)-CD25(+) regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J IMMUNOL , 174 (4) 1783 - 1786.

Grandage, VL; Gale, RE; Lich, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-κB, MAPkinase and p53 pathways. Leukemia , 19 (4) pp. 586-594. 10.1038/sj.leu.2403653.

Grandage, VL; Gale, RE; Linch, DC; Khwaja, A; (2005) PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappa B, MAPkinase and p53 pathways. LEUKEMIA , 19 (4) 586 - 594. 10.1038/sj.leu.2403653.

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro and in cellular assays. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 6 - 6). BLACKWELL PUBLISHING

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976, a novel and potent inhibitor of JAK2 and JAK3, reduces constitutive STAT activity and induces apoptosis in myeloid leukaemia and anaplastic lymphoma cells. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Gregg, R; Smith, CM; Clark, FJ; Dunnion, D; Khan, N; Chakraverty, R; Nayak, L; (2005) The number of human peripheral blood CD4(+) CD25(high) regulatory T cells increases with age. CLIN EXP IMMUNOL , 140 (3) 540 - 546. 10.1111/j.1365-2249.2005.02798.x.

Guenther, MG; Jenner, RG; Chevalier, B; Nakamura, T; Croce, CM; Canaani, E; Young, RA; (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A , 102 (24) pp. 8603-8608. 10.1073/pnas.0503072102.

Guest, RD; Hawkins, RE; Kirillova, N; Cheadle, EJ; Arnold, J; O'Neill, A; Irlam, J; (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens. J IMMUNOTHER , 28 (3) 203 - 211.

Gurardel, A; Barat-Houari, M; Vasseur, F; Dina, C; Vatin, V; Clment, K; Eberl, D; (2005) Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet , 6 19-. 10.1186/1471-2156-6-19. Gold open access

H

Hackshaw, AK; (2005) Passive smoking; what is it and why is it harmful? In: Britton, J and Edwards, R, (eds.) Going smoke-free: the medical case for clean air in the home, at work and in public places. A report on passive smoking of the Tobacco Advisory Group of the Royal College of Physicians. (pp. 1-11). Royal College of Physicians

Hackshaw, AK; Knight, A; Barrett-Lee, P; Leonard, R; (2005) Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer. BRITISH JOURNAL OF CANCER , 93 (11) pp. 1215-1221. 10.1038/sj.bjc.6602858.

Haines, BP; Gupta, R; Jones, CM; Summerbell, D; Rigby, PW; (2005) The NLRR gene family and mouse development: Modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Developmental Biology , 281 (2) pp. 145-159. 10.1016/j.ydbio.2005.01.030.

Hardcastle, IR; Ahmed, SU; Atkins, H; Calvert, AH; Curtin, NJ; Farnie, G; Golding, BT; (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. BIOORG MED CHEM LETT , 15 (5) 1515 - 1520. 10.1016/j.bmcl.2004.12.061.

Harish, S; Saifuddin, A; Cannon, SR; Flanagan, AM; (2005) Synovial chondromastosis of the foot presenting with Lisfranc dislocation. Skeletal Radiology , 1 10.1007/s00256-005-0923-x.

Harlaar, N; Butcher, LM; Meaburn, E; Sham, P; Craig, IW; Plomin, R; (2005) A behavioural genomic analysis of DNA markers associated with general cognitive ability in 7-year-olds. J.Child Psychol.Psychiatry , 46 (10) pp. 1097-1107. 10.1111/j.1469-7610.2005.01515.x.

Harney, J.A.; (2005) An investigation of low dose hyper-radiosensitivity - Does it have a role clinically? Doctoral thesis, University of London. Green open access
file

Harrison, CN; et, A; (2005) Hydroxyurea compared with anegralide in high risk essential thrombocythaemia. New England Journal of Medicine , 353 (1) pp. 33-45.

Harrison, P; Mackie, I; Mathur, A; Robinson, MSC; Hong, Y; Erusalimsky, JD; Machin, SJ; (2005) Platelet hyper-function in acute coronary syndromes. BLOOD COAGUL FIBRIN , 16 (8) 557 - 562.

Hart, DP; Avivi, I; Thomson, KJ; Peggs, KS; Morris, EC; Goldstone, AH; Linch, DC; (2005) Use of F-18-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. BRIT J HAEMATOL , 128 (6) 824 - 829. 10.1111/j.1365-2141.2005.05388.x.

Hartley, JA; Hochhauser, D; Lee, M; Howard, PW; Thurston, DE; (2005) DNA targeting with PBD and polyamide-based agents. In: CLINICAL CANCER RESEARCH. (pp. 9176S - 9176S). AMER ASSOC CANCER RESEARCH

Hartmann, G; Vassileva, V; Piquette-Miller, M; (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. DRUG METABOLISM AND DISPOSITION , 33 (6) pp. 820-828. 10.1124/dmd.104.002568.

Henderson, SR; Guiliano, D; Presneau, N; McLean, S; Frow, R; Vujovic, S; Anderson, J; (2005) A molecular map of mesenchymal tumors. GENOME BIOL , 6 (9) , Article R76. 10.1186/gb-2005-6-9-r76. Green open access
file

Hergovich, A; Bichsel, SJ; Hemmings, BA; (2005) Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. MOL CELL BIOL , 25 (18) 8259 - 8272. 10.1128/MCB.25.18.8259-8272.2005.

Hing, KA; Annaz, B; Saeed, S; Revell, PA; Buckland, T; (2005) Microporosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med , 16 (5) pp. 467-475. 10.1007/s10856-005-6988-1.

Hirschfield, GM; Gallimore, JR; Kahan, MC; Hutchinson, WL; Sabin, CA; Benson, GM; Dhillon, AP; (2005) Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. P NATL ACAD SCI USA , 102 (23) 8309 - 8314. 10.1073/pnas.0503202102.

Ho, EA; Vassileva, V; Allen, C; Piquette-Miller, M; (2005) In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. JOURNAL OF CONTROLLED RELEASE , 104 (1) pp. 181-191. 10.1016/j.jconrel.2005.02.008.

Hoskin, PJ; (2005) Palliative radiotherapy for non-small-cell lung cancer: Which dose? ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Radioisotopes for metastatic bone pain. LANCET LTD, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Evaluation and mangement of the patient with bone metastases at presentation. In: Claude, JE and Rodolfo, CE and Lawrence, CE and Robert, CE and Gerard, S, (eds.) Textbook of Bone Metastases. (pp. 545-554). John Wiley & Sons

Hoskin, PJ; (2005) Overview of treatment.Cancer Pain. In: Stephen, MMK, (ed.) Wall & Melzac's Textbook of Pain. Churchill Livingstone

Hoskin, PJ; Ahmedzai, S; Muers, MF; (2005) Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai, S and Muers, MF, (eds.) Supportive care in respiratory disease. (pp. 463-486). Oxford University Press

Hoskin, PJ; Rojas, AM; Phillips, H; Saunders, MI; (2005) Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Cancer , 103 (11) pp. 2287-2297. 10.1002/cncr.21048.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLINICAL ONCOLOGY , 17 (1) pp. 47-53.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLIN ONCOL-UK , 17 (1) 47 - 53. 10.1016/j.clon.2004.07.004.

Howard, PW; Chen, ZZ; Gregson, SJ; Stephenson, M; Klee, S; Hartley, J; Suggit, M; (2005) Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine PBD) dimer. In: CLINICAL CANCER RESEARCH. (pp. 9015S - 9016S). AMER ASSOC CANCER RESEARCH

Howie, AJ; Pankhurst, T; Sarioglu, S; Turhan, N; Adu, D; (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. KIDNEY INTERNATIONAL , 67 (3) pp. 987-1001. 10.1111/j.1523-1755.2005.00162.x.

Hubbard, T; Andrews, D; Caccamo, M; Cameron, G; Chen, Y; Clamp, M; Clarke, L; (2005) Ensembl 2005. Nucleic Acids Res , 33 (Database) D447-D453. 10.1093/nar/gki138.

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. In: ACTA PAEDIATRICA. (pp. 28 - 33). TAYLOR & FRANCIS AS

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatr Suppl , 94 (447) pp. 28-33.

Hughes, SE; McKenna, WJ; (2005) New insights into the pathology of inherited cardiomyopathy. HEART , 91 (2) 257 - 264. 10.1136/hrt.2004.040337. Gold open access

Hunter, HM; Peggs, K; Powles, R; Rahemtulla, A; Mahendra, P; Cavenagh, J; Littlewood, T; (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRIT J HAEMATOL , 128 (4) 496 - 502. 10.1111/j.1365-2141.2004.05330.x.

I

Ishiko, E; Matsumura, I; Ezoe, S; Gale, K; Ishiko, J; Satoh, Y; Tanaka, H; (2005) Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. JOURNAL OF BIOLOGICAL CHEMISTRY , 280 (6) pp. 4929-4939. 10.1074/jbc.M406788200. Gold open access

Ivins, S; van Beuren, KL; Roberts, C; James, C; Lindsay, E; Baldini, A; Ataliotis, P; (2005) Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. DEV BIOL , 285 (2) 554 - 569. 10.1016/j.ydbio.2005.06.026.

Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M; (2005) Fission yeast Mes1p ensures the onset of meiosis II by blocking degradation of cyclin Cdc13p. Nature , 434 (7032) pp. 529-533.

J

Jacobs, EMG; Hendriks, JCM; van Tits, BLJH; Evans, PJ; Breuer, W; Liu, DY; Jansen, EHJM; (2005) Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. ANAL BIOCHEM , 341 (2) 241 - 250. 10.1016/j.ab.2005.03.008.

Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; (2005) Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. NAT GENET , 37 (5) 520 - 525. 10.1038/ng1549.

Jalal, H; Bibby, DF; Tang, JW; Bennett, J; Kyriakou, C; Peggs, K; Cubitt, D; (2005) First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. J CLIN MICROBIOL , 43 (6) 2575 - 2580. 10.1128/JCM.43.6.2575-2580.2005.

Jenner, RG; Young, RA; (2005) Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol , 3 (4) pp. 281-294. 10.1038/nrmicro1126.

Jenny, C; Toublanc, E; Danos, O; Merten, O-W; (2005) Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells. Cytotechnology , 49 (1) pp. 11-23. 10.1007/s10616-005-5361-z.

Jewell, AP; Cochrane, M; McIntosh, J; Benjamin, R; Nathwani, A; (2005) Comparison of viral vectors for gene transfer into CLL cells: Efficient transduction with adeno-associated virus-8 (AAV-8). In: BLOOD. (pp. 837A - 837A). AMER SOC HEMATOLOGY

Jonathan, C-B; (2005) Freezing used to kill cancer cells. The Sunday Times

K

Kalra, D; Singleton, P; Milan, J; MacKay, J; Detmer, D; Rector, A; Ingram, D; (2005) Security and confidentiality approach for the clinical E-Science framework (CLEF). METHODS OF INFORMATION IN MEDICINE , 44 (2) 193 - 197.

Ke, XY; Miretti, MM; Broxholme, J; Hunt, S; Beck, S; Bentley, DR; Deloukas, P; (2005) A comparison of tagging methods and their tagging space. HUM MOL GENET , 14 (18) 2757 - 2767. 10.1093/hmg/ddi309.

Kelly, CMA; Lee, SM; Steele, JP; (2005) Neoadjuvant chemotherapy for non-small cell lung cancer. In: Andrew, M, (ed.) Key Advances in Lung Cancer. (pp. 67-74). Aesculapius Medical Press: London, San Franscisco and Sydney.

Kendall, AH; Williams, GH; Stoeber, K; Salter, J; Dowsett, M; (2005) Effect of estrogen deprivation on proliferation marker Ki-67 and minichromosome maintenance protein-2 (Mcm-2) in normal postmenopausal breast tissue: potential biomarkers for chemoprevention. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S172 - S172). SPRINGER

Kenny, PA; Enver, T; Ashworth, A; (2005) Receptor and secreted targets of Wnt-I/beta-catenin signalling in mouse mammary epithelial cells. BMC Cancer , 5 , Article 3. 10.1186/1471-2407-5-3. Green open access
file

Keshtgar, MRS; Chicken, DW; Lee, AC; Briggs, GM; Johnson, KS; Clark, B; Pickard, CDO; (2005) Optical biopsy for real-time diagnosis, staging and prognostication. In: (pp. 452-).

Khelifi, AF; D'Alcontres, MS; Salomoni, P; (2005) Daxx is required for stress-induced cell death and JNK activation. CELL DEATH DIFFER , 12 (7) 724 - 733. 10.1038/sj.cdd.4401559.

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) Risks of the complementary medicine Rhodiola rosea in breast cancer. In: (pp. 3048S-3049S).

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) The risks of complementary medicine use (Rhodiola rosea) in breast cancer. In: (pp. 2698S-2698S).

Kim, JB; Stein, R; O'Hare, MJ; (2005) Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis. Tumour Biol , 26 (4) pp. 173-185. 10.1159/000086950.

Kim, JB; Stein, RC; O'Hare, MJ; (2005) Development of a fully "humanized" xenograft model of breast cancer - New ideas for the development of pre-clinical prevention models. International Journal of Cancer Prevention , 2 (2) pp. 87-107.

Kindle, KB; Troke, PJF; Collins, HM; Matsuda, S; Bossi, D; Bellodi, C; Kalkhoven, E; (2005) MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. MOL CELL BIOL , 25 (3) 988 - 1002. 10.1128/MCB.25.3.988-1002.2005.

King-Underwood, L; Little, S; Baker, M; Clutterbuck, R; Delassus, S; Enver, T; Lebozer, C; (2005) Wt1 is not essential for hematopoiesis in the mouse. LEUKEMIA RES , 29 (7) 803 - 812. 10.1016/j.leukres.2004.11.020.

Kingsbury, SR; Loddo, M; Fanshawe, T; Obermann, EC; Prevost, AT; Stoeber, K; Williams, GH; (2005) Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. EXP CELL RES , 309 (1) 56 - 67. 10.1016/j.yexcr.2005.05.027.

Kirk, P; Firmin, DN; Sampson, B; Porter, JB; Walker, MJ; Pennell, DJ; (2005) Validation of T2*technique in ex-vivo myocardial tissue. In: BLOOD. (pp. 7B - 7B). AMER SOC HEMATOLOGY

Knock, J; Shah, M; Wyatt, J; Dixon, M; Casali, G; Lewis, F; Martin, I; (2005) MCM proteins and geminin in gastric cancer: Association with prognosis, histological type, DNA ploidy and proliferation. In: JOURNAL OF PATHOLOGY. (pp. 8 - 8). JOHN WILEY & SONS LTD

Knoll, N; Ruhe, C; Veeriah, S; Sauer, J; Glei, M; Gallagher, EP; Pool-Zobel, BL; (2005) Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol Sci , 86 (1) pp. 27-35. 10.1093/toxsci/kfi171.

Knowles, S; Milkins, C; Stainsby, D; Jones, H; Cohen, H; (2005) Haemolytic transfusion reactions - how many are preventable? In: (Proceedings) British society for haematology annual scientific meeting.

Kocjan, G; (2005) Cytological and molecular diagnosis of lymphoma. J CLIN PATHOL , 58 (6) 561 - 567. 10.1136/jcp.2004.019133.

Kocjan, G; Priollet, BC; Desai, M; Koutselini, H; Mahovlic, V; Oliveira, MH; Pohar-Marinsek, Z; (2005) BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion. CYTOPATHOLOGY , 16 (3) 113 - 119.

Kogelberg, H; Tolner, B; Lowdell, M; Qureshi, U; Robson, M; Dearling, JL; Pedley, RB; (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koonrugsa, N.; (2005) The role of fission yeast microtubule associated protein, Alp14, in microtubule stabilisation and spindle assembly checkpoint maintenance. Doctoral thesis, University of London. Green open access
file

Kostoula, V; Khan, K; Savage, K; Stubbs, M; Quaglia, A; Dhillon, AP; Hochhauser, D; (2005) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? ONCOL REP , 13 (4) 643 - 647.

Kotecha, M; O'Hare, C; Wells, G; Howard, P; Thurston, D; Mantovani, R; Hartley, JA; (2005) Inhibition of DNA binding of the transcription factor complex NF-Y by a pyrrolobenzodiazepine-polyamide conjugate. In: CLINICAL CANCER RESEARCH. (pp. 9016S - 9016S). AMER ASSOC CANCER RESEARCH

Krause, M; Wohlfarth, J; Georgi, B; Pimentel, N; Dorner, D; Zips, D; Eicheler, W; (2005) Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 81 (10) pp. 751-758.

Kristeleit, R; Fong, P; Aherne, GW; de Bono, J; (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clin Lung Cancer , 7 Supp S19-S30.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. BRIT J HAEMATOL , 129 (5) 631 - 643. 10.1111/j.1365-2141.2005.05513.x.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; (2005) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated SCT in patients with multiple myeloma. In: BONE MARROW TRANSPLANTATION. (pp. S49 - S49). NATURE PUBLISHING GROUP

Kröger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; (2005) Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. British Journal of Haematology , 129 (5) pp. 631-643. 10.1111/j.1365-2141.2005.05513.x.

Krtzfeldt, M; Ellis, M; Weekes, DB; Bull, JJ; Eilers, M; Vivanco, MDM; Sellers, WR; (2005) Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell , 18 (2) pp. 213-224. 10.1016/j.molcel.2005.03.009.

Kulkarni, S; Davies, AJW; Treurnicht, K; Dudderidge, TJ; Al-Akraa, M; (2005) Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass. INT J CLIN PRACT , 59 85 - 86.

Kyriakou, C; Attygalle, A; Linch, D; Goldstone, A; Smith, P; Dogan, A; (2005) Angioimmunoblastic T-cell lymphoma: A large series outcome analysis. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 787A-788A). AMER SOC HEMATOLOGY

Kyriakou, C; Thomson, K; D'Sa, S; Flory, A; Hanslip, J; Goldstone, AH; Yong, KL; (2005) Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma. BRIT J HAEMATOL , 129 (6) 763 - 770. 10.1111/j.1365-2141.2005.05521.x.

L

Lagos, D; Bourboulia, D; Vart, R; Trotter, M; Malcles, M; Wang, HW; Boshoff, C; (2005) Kaposi sarcoma herpesvirus: Update. RETROVIROLOGY , 2 , Article S40. 10.1186/1742-4690-2-S1-S40. Gold open access

Lam, L; Diss, TC; Berisha, F; Idowu, BD; Gale, RE; Flanagan, AM; (2005) Differentiation between clear cell sarcoma and malignant melanoma using a molecular approach. In: JOURNAL OF PATHOLOGY. (pp. 5 - 5). JOHN WILEY & SONS LTD

Laman, H; Funes, JM; Ye, H; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. The EMBO journal , 24 (17) pp. 3104-3116.

Laman, H; Funes, JM; Ye, HT; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J , 24 (17) 3104 - 3116. 10.1038/sj.emboj.7600775.

Laurence, AD; Peggs, KS; (2005) Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol , 129 (6) 711-. 10.1111/j.1365-2141.2005.05474.x.

Lawrence, T; Puel, A; Reichenbach, J; Ku, C-L; Chapgier, A; Renner, E; Minard-Colin, V; (2005) Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol , 12 (1) pp. 22-30.

LePla, RC; Landreau, CAS; Shipman, M; Hartley, JA; Jones, GDD; (2005) Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking. BIOORG MED CHEM LETT , 15 (11) 2861 - 2864. 10.1016/j.bcml.2005.03.091.

Ledermann, JA; Frickhofen, N; Wandt, H; Bengala, C; Champion, K; Hinke, A; Moebus, V; (2005) A phase III randomised trial of sequential high dose chemotherapy (HDC) with peripheral blood stem cell support or standard dose chemotherapy (SDC) for first-line treatment of ovarian cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Lee, M; Mahroof, S; Pringle, J; Short, SC; Briggs, TWR; Cannon, SR; (2005) Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy. INTERNATIONAL ORTHOPAEDICS , 29 (6) pp. 403-405. 10.1007/s00264-005-0004-8.

Lee, M; Sato, A; Kim, S; Scott, A; Ellington, M; Frazier, W; Handl, H; (2005) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral seco-CBI analogs and CC-1065. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U344 - U344). AMER CHEMICAL SOC

Little, AM; Clever, S; Torres, HM; Marsh, SGE; Bronwen, S; Madrigal, A; (2005) Donor factors influencing unrelated volunteer donor selection for haematopoietic stem cell transplantation. In: (Proceedings) Joint Meeting of the American-Society-for-Blood-and-Marrow-Transplantation/Center-for-International-Blood-and-Marrow-Transplant-Research. (pp. p. 52). CARDEN JENNINGS PUBL CO LTD

Little, AM; Marsh, SGE; Madrigal, JA; (2005) Histocompatibilty. In: Postgraduate Haematology. (pp. 395-418). Blackwell Publishing: Oxford.

Lo, S; Tolner, B; Taanman, JW; Cooper, JM; Gu, M; Hartley, JA; Schapira, AHV; (2005) Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents. INT J ONCOL , 27 (2) 337 - 344.

Lobo, VJSA; Luquero, CIA; Alvarez-Vallina, L; Tipping, AJ; Viniegra, JG; Losa, JH; Cobo, CP; (2005) Modulation of the p38 MAR (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C. BIOCHEM J , 387 231 - 238. 10.1042/BJ20040927.

Lovat, LB; Jamieson, NF; Novelli, MR; Mosse, A; Selvasekar, C; Thorpe, S; Bown, SG; (2005) Photodynamic therapy with mTHPC for high grade dysplasia and early cancer in Barretts columnar lined oesophagus. Gastrointestinal Endoscopy , 62 pp. 617-623.

M

Macbeth, F; Stephens, R; Hoskin, P; (2005) Radiation dose in spinal cord compression. UNSPECIFIED

Mackenzie, G; Selvasekar, C; Clark, BR; Novelli, M; Thorpe, S; Mosse, C; Bown, S; (2005) Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett's esophagus. In: GASTROENTEROLOGY. (pp. A238 - A238). W B SAUNDERS CO

Mackenzie, GD; Clark, B; Selvasekar, CR; Jamieson, NF; Novelli, MR; Thorpe, SM; Masse, CA; (2005) Photodynamic therapy with 5 aminolevulinic acid for high grade dysplasia in Barrett's oesophagus: Long term follow up of 51 patients. In: GUT. (pp. A15 - A15). B M J PUBLISHING GROUP

Mackenzie, GD; Johnson, K; Novelli, MR; O'Donovan, M; Davies, S; Selvasekar, C; Thorpe, S; (2005) Optical biopsy using elastic scattering spectroscopy can detect dysplasia and cancer in Barrett's oesophagus. In: GUT. (pp. A15 - A15). B M J PUBLISHING GROUP

Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for relapsed Hodgkin and non-Hodgkin lymphoma lowers regimen toxicity and facilitates a graft-versus-lymphoma effect. In: ANNALS OF ONCOLOGY. (pp. 34 - 34). OXFORD UNIV PRESS

Macrae, M; Neve, RM; Rodriguez-Viciana, P; Haqq, C; Yeh, J; Chen, CR; Gray, JW; (2005) A conditional feedback loop regulates Ras activity through EphA2. CANCER CELL , 8 (2) 111 - 118. 10.1016/j.ccr.2005.07.005.

Makris, A; (2005) Report on the 9th International conference on primary therapy of early breast cancer. (Breast Cancer Forum , pp. pp. 2-6 ).

Makris, A; (2005) Tamoxifen and exemestane:to switch or not to switch? UNSPECIFIED

Makris, A; Hisenbeck, SG; Yee, D; Osborne, KC; Elledge, RM; Harrison, M; Ostler, PJ; (2005) A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers. In: (pp. 14S-14S).

Malone, FD; Canick, JA; Ball, RH; Nyberg, DA; Comstock, CH; Bukowski, R; Berkowitz, RL; (2005) First-trimester or second-trimester screening, or both, for Down's syndrome. NEW ENGL J MED , 353 (19) 2001 - 2011. Green open access
file

Manoussaka, MS; Memon, A; Nathwani, A; Porakishvili, N; Clark, E; Lydyard, PM; (2005) Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL). In: BLOOD. (pp. 326B - 326B). AMER SOC HEMATOLOGY

Mansour, MR; Dogan, A; Morris, EC; Khwaja, A; Linch, DC; Mackinnon, S; Peggs, KS; (2005) Allogeneic transplantation for hepatosplenic allphabeta T-cell lymphoma. Bone Marrow Transplantation , 35 (9) pp. 824-829.

Mansour, MR; Dogan, A; Morris, EC; Khwaja, A; Linch, DC; Mackinnon, S; Peggs, KS; (2005) Allogeneic transplantation for hepatosplenic alpha beta T-cell lymphoma. BONE MARROW TRANSPL , 35 (9) 931 - 934. 10.1038/sj.bmt.1704897.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2005) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukaemia. In: BLOOD. (pp. 417A - 418A). AMER SOC HEMATOLOGY

Mansouri, D; Adimi, P; Mirsaeidi, M; Mansouri, N; Khalilzadeh, S; Masjedi, MR; Adimi, P; (2005) Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr , 164 (12) pp. 753-757. 10.1007/s00431-005-1689-9.

Marafioti, T; Pozzobon, M; Hansmann, M-L; Gaulard, P; Barth, TF; Copie-Bergman, C; Roberton, H; (2005) Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia , 19 (5) pp. 856-861. 10.1038/sj.leu.2403702.

Marafioti, T; Pozzobon, M; Hansmann, M-L; Ventura, R; Pileri, SA; Roberton, H; Gesk, S; (2005) The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol , 128 (3) pp. 333-342. 10.1111/j.1365-2141.2004.05313.x.

Marden, CM; North, J; Anderson, R; Bakhsh, IA; Addison, E; Pittman, H; Mackinnon, S; (2005) CD69 is required for activated NK cell-mediated killing of resistant targets. In: BLOOD. (pp. 928A - 929A). AMER SOC HEMATOLOGY

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Tibballs, J; (2005) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolisation as effective as chemoembolisation? Systematic review of cohort and randomized studies. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 384A-384A). JOHN WILEY & SONS INC

Marie-Egyptienne, DT; Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) pp. 5446-5457. 10.1093/nar/gki848.

Marks, AJ; Cooper, MS; Anderson, RJ; Orchard, KH; Hale, G; North, JM; Ganeshaguru, K; (2005) Selective apoptotic killing of malignant hemopoietic cells by anti body-targeted delivery of an amphipathic peptide. CANCER RES , 65 (6) 2373 - 2377.

Marks, D; Oukrif, D; Novelli, M; Forbes, A; Segal, AW; Harbord, M; (2005) Impaired acute inflammation in the terminal ileum of Crohn's patients. In: GUT. (pp. A37 - A38). B M J PUBLISHING GROUP

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update August 2005. Int J Immunogenet , 32 (6) pp. 429-430. 10.1111/j.1744-313X.2005.00555.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update February 2005. Int J Immunogenet , 32 (3) 215-. 10.1111/j.1744-313X.2005.00518.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update January 2005. Int J Immunogenet , 32 (3) pp. 213-214. 10.1111/j.1744-313X.2005.00517.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update June 2005. TISSUE ANTIGENS , 66 (4) pp. 338-340. 10.1111/j.1399-0039.2005.00479.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update March 2005. Int J Immunogenet , 32 (3) pp. 217-218. 10.1111/j.1744-313X.2005.00520.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update October 2004. Int J Immunogenet , 32 (1) 71-. 10.1111/j.1744-313X.2005.00492.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update September 2005. Int J Immunogenet , 32 (6) pp. 431-432. 10.1111/j.1744-313X.2005.00556.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, updated July 2005. Int J Immunogenet , 32 (6) pp. 425-428. 10.1111/j.1744-313X.2005.00544.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for Factors of the HLA System, 2004. Human Immunology , 66 pp. 571-636.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for factors of the HLA system, 2004. TISSUE ANTIGENS , 65 (4) pp. 301-369. 10.1111/j.1399-0039.2005.00379.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for factors of the HLA system, 2004. HUMAN IMMUNOLOGY , 66 (5) pp. 571-636. 10.1016/j.humimm.2005.02.002.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2005) Nomenclature for factors of the HLA system, 2004. International Journal of Immunogenetics , 32 pp. 107-159.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update August 2004. Hum Immunol , 66 (1) 92-. 10.1016/j.humimm.2004.10.011.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update September 2004. Hum Immunol , 66 (1) 93-. 10.1016/j.humimm.2004.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update December 2004. Hum Immunol , 66 (3) pp. 329-330. 10.1016/j.humimm.2005.01.016.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update November 2004. Hum Immunol , 66 (3) 328-. 10.1016/j.humimm.2005.01.015.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update October 2004. Hum Immunol , 66 (3) pp. 326-327. 10.1016/j.humimm.2005.01.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Int J Immunogenet , 32 (5) pp. 325-326. 10.1111/j.1744-313X.2005.00527.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Hum Immunol , 66 (9) pp. 1019-1021. 10.1016/j.humimm.2005.10.003.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update December 2004. Tissue Antigens , 65 (3) pp. 299-300. 10.1111/j.1399-0039.2005.00377.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update February 2005. Hum Immunol , 66 (9) pp. 1015-1016. 10.1016/j.humimm.2005.10.013.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update January 2005. Hum Immunol , 66 (9) pp. 1013-1014. 10.1016/j.humimm.2005.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update July 2005. Hum Immunol , 66 (11) pp. 1183-1186. 10.1016/j.humimm.2005.10.006.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005*. Int J Immunogenet , 32 (5) pp. 329-331. 10.1111/j.1744-313X.2005.00535.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005. Hum Immunol , 66 (9) pp. 1025-1027. 10.1016/j.humimm.2005.10.005.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update March 2005. Hum Immunol , 66 (9) pp. 1017-1018. 10.1016/j.humimm.2005.10.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005*. Int J Immunogenet , 32 (5) pp. 327-328. 10.1111/j.1744-313X.2005.00531.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005. Hum Immunol , 66 (9) pp. 1022-1024. 10.1016/j.humimm.2005.10.004.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update November 2004. Tissue Antigens , 65 (2) pp. 208-209. 10.1111/j.1399-0039.2005.00366.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update October 2004. Tissue Antigens , 65 (2) pp. 206-207. 10.1111/j.1399-0039.2005.00357.x.

Martin, C; Ellis, T; McGurk, CJ; Jenkins, TC; Hartley, JA; Waring, MJ; Thurston, DE; (2005) Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: Footprinting and enzyme inhibition studies. BIOCHEMISTRY-US , 44 (11) 4135 - 4147. 10.1021/bi0479813.

Mauri, P; Scarpa, A; Nascimbeni, AC; Benazzi, L; Parmagnani, E; Mafficini, A; Della Peruta, M; (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J , 19 (7) 1125 - +. 10.1096/fj.04-3000fje.

Mawdsley, S; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 745-752.

Mawdsley, S.K.V.; (2005) The prognostic and therapeutic significance of biological molecular markers in human anorectal carcinomas treated with 5'fluorouracil chemoradiation. Doctoral thesis, University of London. Green open access
file

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, AM; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 (1) 107 - 109. 10.1111/j.1399-0039.2004.00340.x.

Mayor, NP; Cox, ST; McWhinnie, AJ; Argüello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). Tissue Antigens , 65 (1) pp. 107-109. 10.1111/j.1399-0039.2005.00340.x.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Purdy, G; Machin, SJ; (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. PLATELETS , 16 (5) 269 - 280. 10.1080/09537100400020567.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Watt, H; Machin, SJ; (2005) Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J NEUROL NEUROSUR PS , 76 (9) 1249 - 1254. 10.1136/jnnp.2004.051003. Gold open access

McLean, SR; Gana-Weisz, M; Hartzoulakis, B; Frow, R; Whelan, J; Selwood, D; Boshoff, C; (2005) Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val(654)Ala. MOL CANCER THER , 4 (12) 2008 - 2015. 10.1158/1535-7163.MCT-05-0070.

McMahon, K; Hadjur, S; Menzel, U; Kioussis, D; Brady, HJM; (2005) Elucidating the role of MLL in adult murine haematopoiesis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 10 - 10). BLACKWELL PUBLISHING

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2005) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. Pediatric Blood and Cancer , 46 (3) pp. 345-350.

Meaburn, E; Butcher, LM; Liu, L; Fernandes, C; Hansen, V; Al-Chalabi, A; Plomin, R; (2005) Genotyping DNA pools on microarrays: tackling the QTL problem of large samples and large numbers of SNPs. BMC Genomics , 6 , Article 52. 10.1186/1471-2164-6-52. Green open access
file

Mehta, A; Cassiman, JJ; (2005) The pathophysiology of Fabry Disease. Acta Paediatrica , 94 (447) 79-.

Mehta, A; Ginsberg, L; FOS Investigators, ; (2005) Natural history of the cerebrovascular complications of Fabry disease. ACTA PAEDIATRICA , 94 24 - 27. 10.1080/08035320510028076.

Mehta, AB; Cassiman, JJ; (2005) Understanding genotype-phenotype correlations. Acta Paediatrica , 94 (447) 79-.

Mehta, AB; Hughes, DA; (2005) Lysosomal Storage Disorders. In: Postgraduate Haematology. (pp. 318-329).

Mellidez, JC; Mackenzie, G; Selvasekar, C; Novelli, M; Thorpe, S; Mosse, C; Bown, S; (2005) Reversal of Barrett's esophagus following photodynamic therapy using high dose 5 aminolevulinic acid activated by red or green laser light. In: GASTROENTEROLOGY. (pp. A239 - A239). W B SAUNDERS CO

Millar, CM; Starke, R; Riddell, AF; Griffioen, A; Mackie, I; Brown, SA; (2005) Investigation of relationship of von Willebrand factor antigen clearance with ADAMTS-13 activity and Tyr1584Cys polymorphism in type 1 von Willebrand disease. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 46 - 46). BLACKWELL PUBLISHING

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, S; (2005) Thrombotic thrombocytopaenic purpura in human immunodeficiency virus infected patients. International Journal of STD and AIDS , 16 pp. 538-542.

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, SJ; (2005) Thrombotic thrombocytopaenic purpura in HIV-infected patients. INT J STD AIDS , 16 (8) 538 - 542.

Mills, KI; Gilkes, AF; Walsh, V; Sweeney, M; Austin, SJ; Gale, RE; (2005) FLT3 gene mutations in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 29 - 29). BLACKWELL PUBLISHING

Miretti, MM; Walsh, EC; Ke, XY; Delgado, M; Griffiths, M; Hunt, S; Morrison, J; (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. AM J HUM GENET , 76 (4) 634 - 646.

Mittnacht, S; (2005) The retinoblastoma protein--from bench to bedside. Eur J Cell Biol , 84 (2-3) pp. 97-107. 10.1016/j.ejcb.2004.12.012.

Moorman, AV; Harrison, CJ; Richards, SM; Fielding, A; Tallman, MS; Litzow, MR; Rowe, JM; (2005) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 100A-100A). AMER SOC HEMATOLOGY

Morris, E; Mackinnon, S; (2005) Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). TRANSFUSION AND APHERESIS SCIENCE , 32 (1) 73 - 83. 10.1016/j.transci.2004.10.008.

Morris, EC; Mackinnon, S; (2005) Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. BEST PRACT RES CL HA , 18 (1) 129 - 142. 10.1016/j.beha.2004.08.015.

Mulholland, PJ; Thirlwell, C; Brock, CS; Newlands, ES; (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs , 10 (4) pp. 845-854. 10.1517/14728214.10.4.845.

Murphy, RT; Mogensen, J; McGarry, K; Bahl, A; Evans, A; Osman, E; Syrris, P; (2005) Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome - Natural history. J AM COLL CARDIOL , 45 (6) 922 - 930. 10.1016/j.jacc.2004.11.053.

Murrell, A; Rakyan, VK; Beck, S; (2005) From genome to epigenome. HUM MOL GENET , 14 R3 - R10. 10.1093/hmg/ddi110.

N

Nacheva, E; Brazma, D; Foroni, L; Grace, C; (2005) A genome wide screening for genetic imbalances of CML by array CGH. In: (Proceedings) 34th Annual Meeting of the International-Society-for-Experimental-Hematology. (pp. p. 59). ELSEVIER SCIENCE INC

Narat, S; Gandla, J; Dogan, A; Mehta, A; (2005) Successful treatment of hairy cell leukemia variant with rituximab. Leukemia and Lymphoma , 48 (8) pp. 1229-1232.

Narat, S; Gandla, J; Hoffbrand, AV; Hughes, RG; Mehta, AB; (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica , 90 (9) pp. 1273-1274. Gold open access

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. British Journal of Haematology , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. BRIT J HAEMATOL , 128 (1) 3 - 17. 10.1111/j.1365-2141.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. Br J Haematol , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Current hematology reports. , 4 (4) pp. 287-293.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Curr Hematol Rep , 4 (4) pp. 287-293.

Natkunam, Y; Lossos, IS; Taidi, B; Zhao, S; Lu, X; Ding, F; Hammer, AS; (2005) Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood , 105 (10) pp. 3979-3986. 10.1182/blood-2004-08-3112.

Nebot, M; López, MJ; Gorini, G; Neuberger, M; Axelsson, S; Pilali, M; Fonseca, C; (2005) Environmental tobacco smoke exposure in public places of European cities. Tobacco Control , 14 pp. 60-63.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; Nesbitt, SA; (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. Journal of Bone and Mineral Research , 20 (12) pp. 2264-2270. 10.1359/JBMR.050807.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; Nesbitt, SA; (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J BONE MINER RES , 20 (12) 2264 - 2270. 10.1359/JBMR.050807.

Nimmo, R; Antebi, A; Woollard, A; (2005) mab-2 encodes RNT-1, a C-elegans Runx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage. DEVELOPMENT , 132 (22) pp. 5043-5054. 10.1242/dev.02102.

Nooij, MA; Whelan, J; Bramwell, VHC; Taminiau, AT; Cannon, S; Hogendoorn, PCW; Pringle, J; (2005) Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. EUR J CANCER , 41 (2) 225 - 230. 10.1016/j.ejca.2004.08.026.

Norman, MW; Simpson, M; Mogensen, J; Shaw, A; Hughes, S; Sen-Chowdhry, S; Rowland, E; (2005) A novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation , 112 (5) pp. 636-642. Green open access
file

O

O'Brien, F; Sekhavat, M; Lowdell, M; (2005) Long-term storage of cryopreserved autologous bone marrow retains viable haematopoietic progenitor cells. In: (Proceedings) 31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group. (pp. S110-S110). NATURE PUBLISHING GROUP

O'Connell, NM; Saunders, RE; Lee, CA; Perry, DJ; Perkins, SJ; (2005) Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J THROMB HAEMOST , 3 (1) 127 - 138.

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2005) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) pp. 233-239.

O'Shea, C; Klupsch, K; Choi, S; Bagus, B; Soria, C; Shen, J; McCormick, F; (2005) Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J , 24 (6) 1211 - 1221. 10.1038/sj.emboj.7600597.

Oakervee, HE; Popat, R; Curry, N; Smith, P; Morris, C; Drake, M; Agrawal, S; (2005) PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 129 (6) pp. 755-762. 10.1111/j.1365-2141.2005.05519.x.

Obermann, EC; Eward, KL; Dogan, A; Paul, EA; Loddo, M; Munson, P; Williams, GH; (2005) DNA replication licensing in peripheral B-cell lymphoma. J PATHOL , 205 (3) 318 - 328.

Oberst, A; Rossi, M; Salomoni, P; Pandolfi, PP; Oren, M; Melino, G; Bernassola, F; (2005) Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun , 331 (3) pp. 707-712. 10.1016/j.bbrc.2005.03.158.

Ohkura, N; Takahashi, M; Yaguchi, H; Nagamura, Y; Tsukada, T; (2005) Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner. J Biol Chem , 280 (32) pp. 28927-28935. 10.1074/jbc.M502173200. Gold open access

Oses-Prieto, JA; Joubel, A; Rodriguez-Viciana, P; Fried, M; Burlingame, AL; (2005) Use of crosslinking and tandem affinity purification (TAP) methodology to identify new interaction partners of the kinase Mst-2. In: FASEB JOURNAL. (pp. A1397 - A1397). FEDERATION AMER SOC EXP BIOL

P

Padhani, AR; Ah-See, ML; Makris, A; (2005) MRI in the detection and management of breast cancer. Expert review of anticancer therapy , 5 (2) pp. 239-252.

Padhani, AR; Ah-See, ML; Taylor, NJ; Stirling, JJ; Daley, FM; Richamn, PI; d'Arcy, JA; (2005) MRI correlates of tumour grade and hypoxia status in human breast cancer. In:

Pallis, M; Truran, L; Grundy, M; Fisher, J; Hills, R; Moorman, A; Hoy, T; (2005) Functional p-glycoprotein and internal tandem duplications of FLT3 are characteristic of discrete populations of elderly AML patients. British Journal of Haematology , 129 39-.

Palmieri, C; Davis, TN; Dhillon, T; Young, A; Powles, T; Thirlwell, C; Nelson, M; (2005) Pulmonary AIDS related Kaposi sarcoma in the era of HAART. EJC SUPPL , 3 (2) 380 - 380.

Parker, LL; Anderson, FM; O'Hare, CC; Lacy, SM; Bingham, JP; Robins, DJ; Hartley, JA; (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Parsons, M; Monypenny, J; Ameer-Beg, SM; Millard, TH; Machesky, LM; Peter, M; Keppler, MD; (2005) Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol Cell Biol , 25 (5) pp. 1680-1695. 10.1128/MCB.25.5.1680-1695.2005.

Pascolo, S; Ginhoux, F; Laham, N; Walter, S; Schoor, O; Probst, J; Rohrlich, P; (2005) The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int Immunol , 17 (2) pp. 117-122. 10.1093/intimm/dxh191.

Patel, B; Goldstone, AH; Ross, P; Richards, S; Foroni, L; Chopra, R; Fielding, A; (2005) The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 523A-523A). AMER SOC HEMATOLOGY

Pedley, RB; El Emir, E; Sharma, SK; Qureshi, U; Dearling, JAB; R, HJ; (2005) Therapeutic effects of the antivascular agent combretastatin A-1 phosphate on orthotopic and subcutaneous colorectal tumours in nude mice. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 943-).

Peggs, K.S.; Hunter, A.; Chopra, R.; Parker, A.; Mahendra, P.; Milligan, D.; Craddock, C.; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; (2005) The role of alemtuzumab in allogeneic stem cell transplantation. In: Hillmen, P and Witzig, TE, (eds.) Therapeutic Strategies in Lymphoid Malignancy. (pp. 177-188). Informa HealthCare

Peggs, KS; Allison, JP; (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. BRIT J HAEMATOL , 130 (6) 809 - 824.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; Hunter, A; Chopra, R; Parker, A; Mahendra, P; Milligan, D; Craddock, C; (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. LANCET , 365 (9475) 1934 - 1941.

Peggs, KS; Mackinnon, S; Linch, DC; (2005) The role of allogeneic transplantation in non-Hodgkin's lymphoma. BRIT J HAEMATOL , 128 (2) 153 - 168. 10.1111/j.1365-2141.2004.05251.x.

Peleg, M; Steele, R; Thomson, R; Patkar, V; Rose, T; Fox, J; (2005) Open-source publishing of medical knowledge for creation of computer-interpretable guidelines. In: Miksch, S and Hunter, J and Keravnou, E, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 156 - 160). SPRINGER-VERLAG BERLIN

Peltenburg, LTC; de Bruin, EC; Meersma, D; Smit, NPM; Schrier, PI; Medema, JP; (2005) Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ , 12 (6) pp. 678-679. 10.1038/sj.cdd.4401630.

Pennell, DJ; Anderson, LJ; Paul, K; Forni, GL; Ellis, G; Walker, JM; Porter, JB; (2005) Calibration of myocardial T2*values in post-mortem hearts. In: BLOOD. (pp. 40B - 40B). AMER SOC HEMATOLOGY

Perkins, SJ; Gilbert, HE; Lee, YC; Sun, ZF; P, B; (2005) Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. In: Scott, DJ and Harding, SE and Rowe, AJ, (eds.) Modern Analytical Ultracentrifugation: Techniques and Method. (pp. 291-319). Royal Society of Chemistry: London,UK.

Peter, M; Ameer-Beg, SM; Hughes, MKY; Keppler, MD; Prag, S; Marsh, M; Vojnovic, B; (2005) Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. BIOPHYSICAL JOURNAL , 88 (2) pp. 1224-1237. 10.1529/biophysj.104.050153.

Pillay, OC; Wong Te Fong, LF; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; Menon, PA; (2005) The association between polycystic ovaries and endometrial cancer. Human Reproduction

Pina, C; Enver, T; (2005) Transcriptional programming in quiescent human hematopoietic stem cells - Implications for regulation of lineage commitment decisions. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 491A-491A). AMER SOC HEMATOLOGY

Pina, C; Pinto, F; Feij, JA; Becker, JD; (2005) Gene family analysis of the Arabidopsis pollen transcriptome reveals biological implications for cell growth, division control, and gene expression regulation. Plant Physiol , 138 (2) pp. 744-756. 10.1104/pp.104.057935.

Pinheiro, P; Ciau-Uitz, A; Patient, R; Enver, T; (2005) ETV6/TEL1 is required for HSC embryonic development. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 1005A-1005A). AMER SOC HEMATOLOGY

Pinto, ES; Mensah, R; Meeran, K; Cameron, JD; Murugaesu, N; Bulpitt, CJ; Rajkumar, C; (2005) Peripheral arterial compliance differs between races: comparison among Asian, Afro-Caribbeans, and white Caucasians with type 2 diabetes. Diabetes Care , 28 (2) 496-.

Plummer, ER; Middleton, MR; Jones, C; Olsen, A; Hickson, I; McHugh, P; Margison, GP; (2005) Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. CLIN CANCER RES , 11 (9) 3402 - 3409.

Plummer, R; Middleton, M; Wilson, R; Evans, J; Jones, C; Olson, A; Boddy, A;